Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers.

Cancers (Basel) · 2022 · PMC8996885 · PMID 35406520

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendp = 0.09so close (0.05 < p ≤ 0.1)

1.4 months, HR 0.37, one-sided p < 0.0001) and updated analysis showed a trend towards better median OS in the experimental arm (10.3 vs. 7.5 months, HR 0.79, p = 0.09), which may have been impacted by crossover from the placebo to treatment group [ 10 , 38 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.